… the immune response during COVID- 19 disease.(98) COVID- 19 is also characterized by a
decrease in serum total cholesterol. Individuals with inflammatory diseases, including sepsis …

… of disease progression. Findings from this review showed level of C-reactive protein is a
good biomarker to predict the severity of COVID-19 disease. Although COVID-19 researches …

… found to be predictive of COVID-19 severity and may serve as potential biomarkers for
predicting COVID-19 progression and potential targets in therapeutic intervention of COVID-19. …

… As reported, the comorbidities may play an important role in COVID-19. Here, we aim to
address the role of cardiovascular disease (CVD) in the progression and prognosis of COVID-19…

… coronavirus disease 2019 (COVID-19) has rapidly spread to become a worldwide emergency.
Early identification of patients at risk of progression … with moderate COVID-19 pneumonia …

… of patients with coronavirus disease 19 (COVID-19) may overwhelm … factors for disease
severity in the early stages of COVID-19. The … of risk factors for COVID-19 disease progression *. …

… The timely and accurate diagnosis of infection with severe acute respiratory syndrome (SARS)
coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), …

… We studied predictive factors of progression to severe disease to facilitate proper allocation
of patients to different level of medical facilities. Methods: All COVID-19 patients admitted to …

… the widespread COVID-19 disease. More complete details of the epidemiology and clinical
aspects of COVID-19 disease can be found elsewhere. Although clinical disease is usually …

… We studied patients with coronavirus disease 2019 (COVID-19) infected by severe acute
respiratory syndrome coronavirus 2, a virus that originated in Wuhan, China, and is spreading …